cucumerosporus strain L703-4 (ATCC 53784) produces a new 4-methyl-3-hydroxyanthraniloylpentapeptide lactone for which we have proposed the name protactin, in addition to several actinomycin components. Protactin is rather resistant to air oxidation but it can be converted to a new actinomycin, actinomycin Zp by ferricyanide oxidation. Actinomycin Zp possesses in vitro antibacterial activity and in vivo antitumor activity against P-388 leukemia in mice.
hydroxyanthraniloylpentapeptide lactone for which we have proposed the name protactin, in addition to several actinomycin components. Protactin is rather resistant to air oxidation but it can be converted to a new actinomycin, actinomycin Zp by ferricyanide oxidation. Actinomycin Zp possesses in vitro antibacterial activity and in vivo antitumor activity against P-388 leukemia in mice.
In our search for microbial secondary metabolites possessing antitumor activity, we found that Streptomyces cucumerosporus strain No. L703-4, isolated from an Indian soil sample, produced a new antitumor antibiotic designated protactin together with a complex of actinomycins.
This paper describes the production, isolation, structure and biological activity of protactin.
Fermentation of Protactin The producing organism Streptomyces cucumerosporus No. L703-4 was stored and maintained on slants of yeast extract-malt extract agar consisting of glucose 0.4%, yeast extract 0.4%, malt extract 1% and agar 2%, pH 7.0. A vegetative inoculum for shake flask or submerged fermentations was prepared by transferring the mycelial growth from a slant to a 500-ml Erlenmeyer flask containing 100 ml of medium consisting of soluble starch (Nichiden Kagaku) 2%, Pharmamedia (Traders Protein) 1%, ZnSO4 -7H2O 0.003% and CaCO30.4%, the pH being adjusted to 7.0 before sterilization.
The flask were shaken at 28°C for 4 days on a rotary shaker (200rpm) and 5ml of the culture were transferred to an Erlenmeyer flask containing 100ml of the same mediumas described above. The fermentation was carried out at 28°C on a rotary shaker. The fermentation was also carried out in a 200-liter tank fermenter. In this case, 2-liter of the vegetative mycelium was inoculated into the tank containing 120 liters of the medium.Fermentation was run at 28°C with agitation at 250 rpm and aeration rate of 120 liters per minute. Antibiotic production reached a maximumof2 /ig/ml after4 to 5 days in a flask fermentation and 50 hours in a tank fermentation.
The antibiotic titer in fermentation broths was determined by the paper disc agar diffusion assay using Bacillus subtilis M45(rec~) as the test organism and in vitro cytotoxic activity using B16 melanomacells. The production was also monitored by TLC scanning (330 nm) (Shimadzu-Dual Wave Length TLC scanner CS-910). Aconcentrated ethyl acetate extract from the broth filtrate was spotted on a TLCplate RP-18 F254S (Merck Co.) and developed with 70% aq methanol.
Isolation and Purification
The fermentation broth (220 liters, pH 7.3) was separated into mycelial cake and supernate by a Sharpies-type centrifuge (Kokusan H-600 Conversion of Protactin to Actinomycin Zp Uponstanding at roomtemperature in solution, protactin was very slowly converted to a new yellow compound(actinomycin Zp) which showed the same UVspectrum as the actinomycins. Conversion rates under various experimental conditions are listed in Table 1 . This reaction proceeded rapidly and quantitatively upon treatment with potassium ferricyanide1*. Details are described in the Experimental section.
Physico-chemical Properties
The physico-chemical properties ofprotactin and actinomycin Zp are summarized in Table 2 based on microanalysis and mass spectra. The UV spectrum of protactin showed absorption maxima at 217, 257 and 329nm in methanol solution suggesting an anthranilic acid type chromophore2). (Fig. 2) . The IR spectrum exhibited strong absorption at 1750 and 1640cm"1 suggesting that protactin has a depsipeptide structure. This was confirmed by formation of a free acid derivative (m/z 685 (M +Na)+) upon mild alkaline treatment of protactin. The UV absorption maximum at 329 nmin methanol shifted to 290nm in acidic solution and to 343 nmin alkaline solution indicating the presence ofa hydroxy anthranilic acid moiety in protactin. The presence of one amino and one hydroxyl group in protactin was evidenced by the fact that acetylation in pyridine afforded the JV,O-dracetyl derivative (m/z 729 (M +H)+). When hydrolyzed with 6n hydrochloric acid, protactin gave L-threonine, D-valine, sarcosine, Af-methyl-L-valine and an unidentified amino acid as determined by amino acid analysis, TLC and HPLCwith a chiral column. All of the protons and carbons observed in the *H and 13C NMRspectra of protactin were unambiguously assigned using^^H,^C^H,^C^H long range COSYNMRspectra (Table 3 ). The long range COSY revealed that the chromophore and unidentified amino acid were 4-methyl-3-hydroxyanthranilic acid and 5-methylproline, respectively (Fig. 3) . The spectrum also clarified the connectivities of the amino acids and the chromophore establishing the complete structure as shown in Fig. 4 . Actinomycin Zp was assigned the structure in Fig. 4 since it was prepared by potassium ferricyanide oxidation of protactin and has physico-chemical and spectral properties similar to those of the known actinomycins.
Antimicrobial Activity The antimicrobial activity of protactin and actinomycin Zp against aerobic and anaerobic bacteria and fungi was determined by a serial 2-fold agar dilution method. Actinomycin D was used as reference <5 ppm (multiplicity, J= Hz). with the results shown in Table 4 . They are active against aerobic Gram-positive bacteria, weakly active against anaerobic Gram-positive bacteria and inactive against Gram-negative bacteria and fungi. They are about one fourth as active as actinomycin D. Antitumor Activity Protactin and actinomycin Zp were tested for in vitro cytotoxicity against murine and humantumor Moser (human colorectal carcinoma) cells was determined as described previously3). Both protactin and actinomycin Zp were highly cytotoxic, but the latter was more cytotoxic than the former in vitro. Against B16-F10 and Moser cells, the observed IC50 values of protactin were 0.007 and 0.09/ig/ml, those of actinomycin Zp <0.00016 and 0.06/il/ml, and those of actinomycin D 0.002 and 0.9 /ig/ml, respectively. Inhibitory effects of protactin on macromolecular synthesis (DNA, RNAand protein) were determined in vitro. Cultured L1210 murine leukemia cells (5 x 105 cells/ml) were incubated with test materials at 37°C for 15 minutes and then further incubated for 60 minutes after the addition of labeled precursors, [3H]thymidine, [14C]uridine or [3H]leucine, respectively, to the cultured mixtures. After precipitation and washing with cold 5% trichloroacetic acid solution, the radioactivity incorporated into the acid-insoluble fraction of the tumor cells was determined in a liquid scintillation counter. Protactin and actinomycin D inhibited RNAsynthesis stronger than DNAsynthesis, whereas both the compounds showed no inhibitory effect on protein synthesis at 100/xg/ml, the highest concentration tested. In vivo antitumor activities of protactin and actinomycin Zp were tested in tumor-bearing female CDFXmice. After the intraperitoneal implantation of diluted ascitic fluid with 1.0 x 106 lymphocytic leukemia P388 cells into the mice, test compounds were administered intraperitoneally once a day on days 1, 2 and 3 (QD x 3). Both components demonstrated fairly good anti-P388 leukemic activity with maximumT/C values of 160%, similar to that of actinomycin D (Table 5) . molecule has been synthesized chemically4 '5) . Moreover, such a compound lacking an amino group may accumulate in the mediumwhenactinomycin-producing Streptomyces are supplied 3-hydroxybenzoic acid or related analogs6).
Protactin appeares to be the first example of an anthraniloylpentapeptide lactone metabolite discovered as a natural fermentation product and it may prove to be the direct precursor used for the biosynthesis of an actinomycin molecule in vivo. Protactin contains 5-methyl proline which is an unusual constituent present in the peptide moiety of actinomycin Z57'8) and Schering la and lb9). By contrast, actinomycin Zp, formed by chemical oxidation is a new actinomycin that possessed two residues of 5-methylprolines in the molecule. Although protactin exhibited antimicrobial and antitumor activity under the experimental conditions employed, at least a part of this activity may be due to actinomycin Zp synthesized during incubation. Further tests are needed to clarify whether protactinper se has significant biological activity.
Experimental
TLCwas performed on precoated silica gel plates (Kieselgel 60F254, Merck). IR and UV spectra were recorded on a Jasco IR-8 10 spectrophotometer and a Jasco UVIDEC-610C spectrophotometer, respectively.
EI-MS and SI-MS spectra were measured on a Hitachi M80B,and HREI-MSon a Jeol JMS-DX-300 mass spectrometer. lH and 13C NMRspectra were recorded on a Jeol JMN-GX400 spectrometer operated in Fourier transform mode. Aminoacid analysis was carried out using the Waters PICO-TAGsystem.
Conversion of Protactin to Actinomycin Zp
A solution of protactin (1, 20mg) in methanol (5ml) was added to a stirred solution of potassium ferricyanide (30mg) in 0.067 m phosphate buffer (pH 7.1, 5 ml). After stirring at room temperature for 10 minutes, the solution was diluted with water (20ml) and extracted 3 times with 15ml portions of ethyl acetate. The combinedextracts were dried over sodium sulfate and evaporated to afford a homogeneous solid of actinomycin Zp (17mg). 
